Stocks
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -171.4% | -83.9% | -43.6% | -62.4% | -35.3% | 9.35% | ||
| Changes by years, y/y, % | -58pp | +87pp | +40pp | -19pp | +27pp | -20.9% | |||
Sarepta Therapeutics. EBITDA margin, %
Sarepta Therapeutics. EBITDA margin, changes, pp
Sarepta Therapeutics (SRPT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -6.28% | 15.3% | 14.1% | 3.31% | 4.75% | 9.35% | |
| Changes by years, y/y, % | +42pp | +47pp | +57pp | +42pp | +11pp | |||
| Changes by quarters, q/q, % | +33pp | +22pp | -1pp | -11pp | +1pp | |||
